• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPfizer

Pfizer

Page 4 of 37
Pfizer-BioNTech ‘surprised’ by Moderna lawsuit alleging they copied COVID-19 vaccine technology
HealthPfizer-BioNTech ‘surprised’ by Moderna lawsuit alleging they copied COVID-19 vaccine technology
By Chloe TaylorAugust 26, 2022
A vial of the Moderna COVID vaccine
HealthAn FDA change to vaccine authorization allowed Pfizer and Moderna to apply for BA.5 booster approval without key data
By Nicholas GordonAugust 24, 2022
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
FinanceThe world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By Paige McGlauflinAugust 15, 2022
COVID finally got me. Will it come for you?
CommentaryCOVID finally got me. Will it come for you?
By Carolyn BarberJuly 12, 2022
FDA clears Pfizer and Moderna vaccines for kids under 5
HealthFDA authorizes Pfizer and Moderna COVID vaccines for children under 5
By Fiona Rutherford and BloombergJune 17, 2022
These are the most inspirational CEOs on the Fortune 500
LeadershipThese are the most inspirational CEOs on the Fortune 500
By Marco Quiroz-GutierrezMay 26, 2022
Pfizer says it will slash drug prices for the poorest nations. But the devil is in the details
HealthPfizer says it will slash drug prices for the poorest nations. But the devil is in the details
By Drew Armstrong and BloombergMay 25, 2022
Pfizer vaccine for youngest kids
HealthPfizer says three COVID shots is ‘highly effective’ in children under 5
By Riley Griffin and BloombergMay 23, 2022
Boy receives COVID-19 vaccine
HealthFDA authorizes Pfizer booster for children ages 5 to 11
By Lauran Neergaard and The Associated PressMay 17, 2022
Companies should be guided by their purpose and values when deciding whether or not to exit Russia
CommentaryCompanies should be guided by their purpose and values when deciding whether or not to exit Russia
By Hubert JolyMay 12, 2022
Pfizer CEO says ‘a vaccine that will last at least a year is the holy grail right now’
HealthPfizer CEO says ‘a vaccine that will last at least a year is the holy grail right now’
By Megan LeonhardtMay 10, 2022
Child receives COVID-19 vaccine
HealthFDA sets June meetings on COVID vaccines for youngest kids
By The Associated PressApril 29, 2022
Europe won’t have an Omicron-adapted mRNA vaccine until at least autumn
HealthEurope won’t have an Omicron-adapted mRNA vaccine until at least autumn
By Christiaan HetznerApril 27, 2022
President Joe Biden
HealthBiden to expand availability of COVID antiviral pill Paxlovid
By Zeke Miller and The Associated PressApril 26, 2022
A pharmacy manager in Chicago holds a package of Pfizer Paxlovid pills
HealthWe’re about to make the same mistake with COVID treatments that we did with vaccines, WHO says
By David MeyerApril 22, 2022
1
  • 2
  • 3
  • 4
  • 5
  • 6
...37
Most Popular
Economy
Jerome Powell says the $39 trillion national debt is ‘not unsustainable,’ but warns the trajectory ‘will not end well’placeholder alt text
By Fortune EditorsMarch 30, 2026
Success
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strainplaceholder alt text
By Fortune EditorsMarch 31, 2026
Personal Finance
Kevin O'Leary says if you earn $68,000 a year and follow this rule, you'll retire a millionaireplaceholder alt text
By Fortune EditorsMarch 31, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.